Santiago Appiani

Title: Innovations in Drug Delivery: The Work of Santiago Appiani

Introduction

Santiago Appiani is an accomplished inventor based in Redwood City, CA. He has made significant contributions to the field of drug delivery, particularly in the treatment of eye diseases. With a total of 2 patents, his work focuses on innovative dendrimer compositions that enhance therapeutic efficacy.

Latest Patents

Appiani's latest patents include groundbreaking methods for drug delivery to the eye. These dendrimer compositions are designed for the treatment of inflammatory and angiogenic diseases affecting the eye. The compositions utilize hydroxyl-terminated dendrimers that are complexed or conjugated with active agents, such as VEGFR tyrosine kinase inhibitors, including sunitinib. These innovative formulations are intended for systemic administration to effectively target activated microglia and macrophages in the retina and choroid.

Career Highlights

Santiago Appiani is currently associated with Ashvattha Therapeutics, Inc., where he continues to develop advanced therapeutic solutions. His work is pivotal in addressing complex ocular diseases, showcasing his commitment to improving patient outcomes through innovative drug delivery systems.

Collaborations

Appiani collaborates with notable professionals in the field, including Jeffrey L. Cleland and Rishi Sharma. These partnerships enhance the research and development efforts at Ashvattha Therapeutics, Inc., fostering a collaborative environment for innovation.

Conclusion

Santiago Appiani's contributions to drug delivery systems represent a significant advancement in the treatment of eye diseases. His innovative approach and dedication to research continue to pave the way for future breakthroughs in the field.